Safety and cost-effectiveness of single dose dispensing of bevacizumab for various retinal pathologies in developing countries.

Velpandian, T; Sharma, C; Garg, S P; Mandal, S; Ghose, S

Velpandian, T; Sharma, C; Garg, S P; Mandal, S; Ghose, S.

Indian J Ophthalmol ; 2007 Nov-Dec; 55(6): 488-90

Article in En | IMSEAR | ID: sea-70911

Subject(s)

Angiogenesis Inhibitors/economics; Antibodies, Monoclonal/administration & dosage; Cost-Benefit Analysis; Developing Countries; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Packaging/economics; Humans; Retinal Diseases/drug therapy

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Retinal Diseases / Humans / Cost-Benefit Analysis / Angiogenesis Inhibitors / Developing Countries / Dose-Response Relationship, Drug / Drug Packaging / Drug Dosage Calculations / Antibodies, Monoclonal Type of study: Health_economic_evaluation Language: En Journal: Indian J Ophthalmol Year: 2007 Type: Article

Fulltext

Add to My VHL

XML

Search on Google